Nexalin Technology, Inc. received a notification letter from NASDAQ stating it is not in compliance with the minimum bid price requirement of US$1.00 per share. The Company has 180 days to regain compliance by maintaining a closing bid price of at least US$1.00 for 10 consecutive trading days. Failure to comply may result in delisting. Nexalin is monitoring its bid price and exploring options to improve financial position. The company’s neurostimulation products aim to combat mental health issues and have been approved in multiple countries. Forward-looking statements caution risks and uncertainties. Contact Crescendo Communications, LLC for more information.

Read more at GlobeNewswire: Nexalin Technology Receives Nasdaq Listing Status